Health Ministry Of Türkiye Republic Ankara Bilkent City Hospital

Ankara 6800

0 studies enrolling now · 3 studies all time

What they study most

Acute Non-cardioembolic Ischemic Stroke, Atrial Fibrillation, High-risk Transient Ischemic Attack, Prevention of Ischemic Stroke, Prevention of Stroke or Systemic Embolism, Solid Tumors Harboring NTRK Fusion

Studies at this site

• A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid Tumors — Completed
• A Study to Test Asundexian for Preventing a Stroke Caused by a Clot in Participants After an Acute Ischemic Stroke or After a High-risk Transient Ischemic Attack, a So-called Mini Stroke — Completed
• A Study to Learn How Well the Study Treatment Asundexian Works and How Safe it is Compared to Apixaban to Prevent Stroke or Systemic Embolism in People With Irregular and Often Rapid Heartbeat (Atrial Fibrillation), and at Risk for Stroke — Stopped early